April 15 of lung cancer patient were then targeted therapy

 Before entering the interview, we recommend users look at the following two videos:
First, the Chinese Academy of Medical Sciences Cancer Hospital Professor Shi Yuankai about the treatment of advanced lng cancer
Second, our well-known lung cancer expert, Professor Wu Yilong Guangdong Provincial People's Hospital, about lung cancer Interview with the latest progress of the treatment
theme: rainbow leap of life, so life is no longer helpless
mm Sohu series of interviews on the health of the patient tumors were then targeted therapy for lung cancer
interview guest: Chinese Academy of Medical Sciences Professor Shi Yuankai
Cancer Hospital, Shanghai Chest Hospital, Tongji University, Shanghai Pulmonary Hospital Professor Han Baohui
Professor Zhou Caicun
Cancer Hospital Affiliated Professor Zhang Li
lung cancer patients following interview
Record:
Moderator: Good afternoon, friends, Welcome to Sohu health interview, the invited guests today can be described as luxury lineup. is from Beijing, Shanghai and Guangzhou of lung cancer specialists, three are domestic authority in the field of lung cancer. They are the Chinese Academy of Medical Sciences Cancer Hospital, vice president, oncology director Professor Shi Yuankai, Shanghai Jiaotong University Affiliated Shanghai Chest Hospital, Professor Han Baohui director of pulmonary medicine, there is a director of Tongji University, Shanghai Pulmonary Hospital Oncology Professor Zhou Caicun, the other One is a Cancer Hospital Affiliated Professor Zhang Li, deputy director of internal medicine.
In particular, we invited a special guest, he is a lung cancer patient, interview his own personal experience will tell you experts and netizens He tells about the experience of the struggle with lung cancer.
now officially entered the interview.
why the high incidence of lung cancer?
Moderator: current threat to human health, lung cancer has become the second largest killer. Now Lung Cancer disease situation, first of Professor Han Baohui make a brief introduction.
Shanghai Chest Hospital, Professor Han Baohui
Han Baohui: Good afternoon netizens. We are very pleased to Beijing and Guangzhou for tumor promotion experts weeks to do publicity, we know that lung cancer is a serious threat to people's health cancer, its incidence in men is the first, second place in the female.
epidemiological data based on our country, in 2005 the information on each of diagnosis of lung cancer in our country, nearly 50 million people, is a very large crowd. This gives us an expert in cancer treatment presents a serious issue. also led us to better use weapons and the means to provide a good treatment of patients with lung cancer. We are very pleased with such a platform Cancer Awareness Week, the latest cancer treatment information and ideas and concern for the majority of lung cancer patients and people to do publicity and presentation. I hope we can promote the introduction and prevention and treatment of lung cancer, especially in the treatment able to provide some meaningful information.
Moderator: Professor Han by just the introduction, we know that lung cancer incidence in China has now is very serious. then able to briefly explain The reasons for the increased incidence of what?
Han Baohui: Lung cancer is the cause of a comprehensive, exact reasons still under study, but are more common reason is smoking. specific responses, the first is the creation of a healthy, smoke-free environment, which is the most important.
Moderator: introduction by Professor Han, we see that the incidence of lung cancer has increased this year, with the increase in the incidence of it in recent years for lung cancer What progress in treatment? Please make a brief introduction Professor Zhou.
Tongji University, Shanghai Pulmonary Hospital Professor Zhou Caicun
ZHOU Cai-cun: We know that these specific tumor pathogenesis. We developed a new targeted drugs has been applied to the clinical treatment of lung cancer. I think the first point is combined with chemotherapy can be discussed, combined with our past treatment of the platform, there are a lot of progress effect. for the epidermal growth cycle, cell wall treatment, have played a very good role. compared with chemotherapy alone, significantly reduced pain in patients. This is worth something happy patients and medical staff.
how early detection of lung cancer
Moderator: early detection of lung cancer is not very difficult? < br> Han Baohui: Lung cancer is actually a source of fat in the lung disease, and its manifestations are many and varied. a lot of performance is not associated with the respiratory tract. So we emphasize the diagnosis of lung cancer, the first of a regular medical examination to emphasize , for example, more than 45 years of age, family history, smoking habits of patients, which is high-risk groups, to regular inspection, rather than the onset of symptoms later examination. If you check the gap period in peacetime, there has been sputum with bloodshot eyes, or the symptoms of chest tightness, etc., do not let your guard down, but also timely to the hospital to be checked. Of course, there are many aspects of this examination, including blood tests, including chest perspective, when necessary, examination of sputum, or Dialysis is a chest scan. By doing this, an early discovery of the tumor. because most early tumors are more hidden. we first have to be vigilant, while the second time check, the third time in a lung, we should check in advance .
Moderator: There are national screening program for lung cancer for you?
Hanbao Hui: We attach great importance to this country, but also put a lot of funds in the National Eleventh Five-added research projects such a project. early lung cancer screening is a very vast projects. This involves health economics, namely, the number of state and government to invest money found a patient. the existing methods, our examination of sputum every six months, sub- of scanning, or physical examination is necessary. But the question is who will pay for this investment is? I think this need for reasonable arrangements to achieve the best economic investment to produce the best results. both to maximize identify problems, and better use of resources.
Moderator: Most of the clinical experience of lung cancer in the late fall, Professor Zhou's friends can explain to us what kind of lung cancer are the late ?
ZHOU Cai-cun: Because there are no symptoms of early lung cancer, there are symptoms of a medical point of view of our time, most have been to the middle and late, and lost opportunities for surgery. In our patients, two-thirds of patients are late or close to the late opportunities. terminally ill patients or patients with locally advanced, through our current treatment is chemotherapy or radiotherapy, are often relatively poor efficacy. so we should pay attention to the issue of early detection.
I think that some patients should be highly alert to the occurrence of lung cancer. For example, high-risk groups, there are some unexplained shoulder, often without relief of pain, pneumonia is always the same position, or is unexplained, hypertrophy of bone and joint patients, we should make the check to rule out the possibility of lung cancer, which is our emphasis on early diagnosis. early stage lung cancer patients, usually in three previous patients, we believe that there are opportunities for demobilized. Once discovered, can be cut patients, let them do surgery, if the inoperable patients, we mainly with chemotherapy or radiotherapy.
Moderator: two experts in the treatment process has not encountered any particular typical example, patients can adjust their attitude, has been fighting lung full of defeat?
Hanbao Hui: We do today's theme is a new method of treatment of lung cancer in the past, we faced a lot of advanced lung cancer patients, radiation therapy if he failed, he lost the treatment. If he can not do chemotherapy, he also lost his treatment. such as some elderly patients, he was diagnosed when the body is weak, the chemotherapy and radiation therapy are difficult, we will be helpless.
since the advent of targeted therapy, we have a very good drug, after the failure of chemotherapy can still achieve very good results. This is the targeted therapy brings new hope to patients.
so I give the majority of patients made some comments, advanced cancer does not mean there is no hope, we are now with the development of technology, with the advent of new drugs constantly, constantly enriched with the treatment, the treatment combination of new methods, new technologies to enter, I would like to , our future treatment of advanced lung cancer, can have more than a combination of means to achieve better patient. So, I think patients should have advanced the confidence of our cancer patients can achieve better results. This I give the majority of patients that bring this information, I hope they do indomitable courage and fight disease.
the case of standard treatment of lung cancer
Moderator: So the treatment of lung cancer should go by. below Professor Shi Yuankai, please give us a brief introduction, the case of standard treatment of lung cancer.
Cancer Hospital, Chinese Academy of Medical Sciences Professor Shi Yuankai
Shiyuan Kai: the so-called standard treatment, that is, a large number of clinical studies based on the results of clinical studies to different types of diseases, and different stage of disease, and various disease states, patient physical condition, etc., developed a standardized treatment. is based on a large number of clinical studies, the clinical is the so-called Our original approach with which approach is better than it? If the new treatment options is good, we should adopt a new treatment approach, the only way we can allow patients to get the maximum, the best benefit, we can make reduce unnecessary treatment of patients with the hassle, or pain and setbacks. these norms, that is, on the basis of a large number of clinical studies developed. only in accordance with the implementation of such a specification, to be able to get the most benefit for patients.
Moderator: lung cancer points one, two, three and four. like this one, two, three, four phases of lung cancer, their treatment is differentiated?
Dan Yuankai: Lung cancer in accordance with international The staging can be divided into one, two, three, four. the first and second is more limited, Phase III is extensive, more than three virtually no chance of treatment.
patients with early After we reasonably comprehensive treatment based on surgery can allow patients to get better results. three or more, four phases of lung cancer based mainly on the body, surgery is basically no chance. one of the lung, the main is surgery, after surgery, is not used too much of adjuvant chemotherapy and radiotherapy. If there are special factors that bad, you can consider making some appropriate adjuvant chemotherapy, but the vast majority do not do. two of the patients is mainly postoperative chemotherapy after surgery did not do radiation. For three or four patients in the patient, because there is no chance of surgery, mainly in the main body treatment.
how to treat patients with lung cancer?
Moderator: Professor Zhang Li, advanced lung cancer patients how to present treatment? Professor Zhou told us just a moment, 80% belong to the late, late stage of lung cancer patients quality of life and survival through treatment to be able to have any improve?
Affiliated Tumor Hospital of Sun Yat-sen Professor Zhang Li
tension: the treatment of advanced lung cancer patients progress over the past decade the situation is good. Twenty years ago, the treatment effect is very poor, efficiency is 10%. Twenty years ago, lung cancer survival rate of only about 10% a year, this data is relatively low, with no treatment, not much difference. Ten years ago we started to progress. We use the older program, one-year survival rate reached 20% to 30%. In recent years, the emergence of three generations of drugs, we can increase the survival rate one year to 40%. We in the twenty years, the survival rate of patients with advanced lung cancer four times. most of the late The patient can live a year, but two years or not, this is our current treatment status.
reflected as targeted therapy, in particular, there's a new drug market, the emergence of these drugs, we can 50% of patients survive one year later. His survival may exceed 12 months, we can see in the next two or three years, the next research goal is to the survival of advanced lung cancer two years ahead of the . Although we cure cancer, can not eradicate the tumor, but you can bring the patient survival.
Moderator: previous treatment for advanced lung cancer are mostly chemotherapy, but the side effects of chemotherapy is also great, very painful in some patients . because most of them are elderly people with advanced lung cancer accounted for the majority, for such patients, is not it more suitable for targeted therapy?
tension: can not be completely absolute. Generally speaking, chemotherapy, chemotherapy than non-chemotherapy patients patients, on the one hand to improve the quality of life, on the other hand, survival also increased. So, as we currently do not the so-called life, there is chemotherapy, chemotherapy is more than we do over a period of time. not for all people Targeted therapy is effective. For me, one more targeted therapy, for our more than a means of treatment, one more to add. rather than saying it targeted therapy after chemotherapy had no effect. And We hope to get more patients and more effective treatment. We want a more objective look at this issue.
the efficacy of targeted therapies and the application of the crowd
Moderator: Professor Han then please give us friends introduce specific targeted therapy for advanced lung cancer how? bring it to our patients what the benefits?
Hanbao Hui: We are in advanced cancer therapy, or to play the advantages of various treatments. such as chemotherapy efficiency can reach 30%, previous chemotherapy, if invalid, may we at his wits end. But now we have added a targeted therapy.
targeted therapy in our country now have two drugs, one is Tarceva, Iressa, both drugs effective treatment of lung cancer rate of up to 7% to 20%. This and the effect of chemotherapy is quite. but its advantage is that, for advanced tumors, even if chemotherapy is invalid, or chemotherapy ineffective, and relatively poor physical and chemotherapy patients with poor conditions, and then use targeted therapy, also can play a better therapeutic effect. Another point, short-term chemotherapy can be close to 30% efficiency, but we can see a higher ratio is obtained by targeted therapy, to achieve 70% to 80% of the disease control rate, patient is stable, reasonable living.
we can not completely cure the cancer out, but we can let patients and coexistence of tumor and the survival of good quality. This is our short-term goal of the treatment of cancer. not completely overcome the tumor out, but let him live longer and live better. This is a targeted therapy can give advanced lung cancer patients the greatest gospel. targeted therapy we have one more choice, more than any other weapons.
Moderator: Professor Zhou is now able to introduce specific targeted therapy can be used for which patients? is not After the failure of the first chemotherapy treatment must be to use targeted drugs?
ZHOU Cai-cun: in the late second or third-line lung cancer cases, according to the economic situation of the patient to select the targeted therapy. For the first-line patients, if you can not do chemotherapy, or is the old patients, we can use first-line targeted therapy. such as patients over 80 years, chemotherapy has not been possible to use. For such patients, we can use targeted therapy. Similarly, a relatively poor PS (PS score should reach one-third, quarter), PS two points, a relatively high age of patients, we may consider targeted therapy. we generally think that, in the first-line chemotherapy, the tumor growth in patients, targeted therapy is the most appropriate a group of people. first-line chemotherapy is relatively large, in the second-line treatment, we can give priority to select the targeted therapy. or the first-line treatment after a body is poor, we can choose targeted therapy. to a third-line therapy after targeting treatment can play a leading role. In the third line, after chemotherapy, the patient used twice, we can choose targeted therapy.
which patients better use of targeted drug therapy
Moderator: For patients, whether to use targeted therapy there are individual differences? some people sensitive to drugs, medication effects, and some not so good treatment.
tension: clinical results from the present perspective, the current targeted therapy There are some advantages of the so-called people. such as the drug Tarceva, may have gene mutations in patients, or patients with overexpression of genes may be a more appropriate population. Similarly, these groups are compared to chemotherapy sensitive populations.
far, we have unraveled the mystery of science. because the targeted therapy is a choice of people, certainly there are ways to help us identify which people can more easily benefit. from the existing practices first-line treatment when we stand now do its own choice, second-and third-line do we advocate for patient choice. Generally speaking, the second and third tier of the patients we advocate targeted therapy for patients try.
chair man: identification of these third-line patients, we do not have clear evidence to prove that a mutation is more likely to benefit patients, you can not prove that no mutation of the patients can not benefit. For those patients with advanced, second and third-line therapy, has been do not have much choice, so that patients, if there is hope, we must give patients more choice of treatment.
tension: the angle of detection there is a problem, we know that if you want to test a project, to be an open project, but also through price approval before they can carry out our routine testing. At present, test method if using existing technology, about two thousand dollars to spend about a week or two need to weeks between the need to be of human, material consumption. there part of the technically limited, not every patient can do.
Moderator: current clinical application targeted therapy for patients with advanced lung cancer How much efficiency can be achieved?
tension: If the three indicators at the same time with its efficiency is 50%. We do not have clear indicators, clinical indicators have been used as first-line number to use, while three indicators available, it is may be considered first-line treatment for targeted therapy. If the current treatment options targeting the population higher than conventional chemotherapy, I can not be considered first-line chemotherapy in patients with targeted therapy. including our experts sit in to do this several research in this area. Through these relatively simple methods, are useful in the field to find some patients so that you can take personalized treatment to patients, rather than uniform chemotherapy.
Shiyuan Kai: So, this year a number of international standards measures began to lung cancer treatment recommended for those who do are more likely to benefit from targeted therapy for patients.
targeted therapies that are effective performance
rash Moderator: We all know the side effects of cancer chemotherapy is very obvious, there may be hair loss, and some bone marrow suppression. For this new targeted therapy, which is what the side effects?
Dan Yuankai: targeted therapy has some side effects, but the chemotherapy phase and ratio, light a lot. The most common side effects are skin rash, and diarrhea, nail and skin damage. such damages most cases are relatively mild, the patient can tolerate.
Moderator: For the target side effects to the treatment resulted in a rash, the patient should be how to treat?
tension: As you know, our drug called epidermal growth factor network histidine kinase inhibitors. the so-called targeted therapy, compared with our traditional treatment, but higher selectivity only. rashes is a common side effect of targeted therapy. Meanwhile, in the clinical setting, doctors judged it as a indicator of efficacy. If there is a rash, probably the same in the body will achieve the same effect. Therefore, skin rash, for the doctors concerned, is to see a good news, marks the drugs on the tumor plays a role. Therefore, under normal circumstances we will do with the patient to explain, to tell the patient the rash is likely to represent you is the onset of the patients a drug, or a patient benefit, but if a very powerful, we may have some ways to help alleviate the symptoms of the patient.
February this year we are in the specialized experts in the field of lung cancer organized the drafting of a targeted therapy drug therapy rash of consensus, a consensus that we learn through this targeted therapy can handle the situation caused by the rash. and his treatment effect is quite satisfactory. rashes on the one hand is a good message, on the other hand, it can be controlled.
Moderator: rash later is will slowly subside?
Shiyuan Kai: If the word rash reflect a relatively significant number of the beginning, the vast majority of patients As the treatment time, coupled with the control of the rash the doctor, such as a very serious skin rash, the doctor may consider stopping the medication a little one day, or reduce the dosage. such treatment, most patients over a period of time rash will get better relief. a large number of foreign studies have demonstrated the severity of the rash, or skin rash is not out of the efficacy and patient are relevant. So we were going well explained by the patient and hope the patient can be a positive match with the doctor, take some positive measures to enable the vast majority of patients can continue to be treated well.
targeted therapy in lung cancer patients should pay attention to what?
Moderator: For targeted therapy in patients with advanced lung cancer during the process, we should pay attention to what?
ZHOU Cai-cun: first to note that skin rash is the most common side effects of targeted therapy. I recommend that patients try to avoid the sun. Secondly, I suggest that you use, it should use the more moderate wash supplies, for easy hair is easy to send athlete's foot, or periodontitis patients, but also pay attention to. Again, I remind you that the rash is the effect of the signal continuously, but also efficacy standard.
need to draw our attention are diarrhea, skin rashes and we know, in-house to cause diarrhea, diarrhea is appeared after the second week, reached a peak in about 15 days, if the patient once they reach the peak , I recommend that patients use drugs targeted against diarrhea. Our clinical findings have some side effects of the drug Tarceva, but after using the drug treatment, symptoms can be alleviated. Third, we must periodically check liver function, we found Targeted therapy also can cause liver damage, it is recommended you in a month or so, check liver function. In clinical practice, we usually give the patient the patient about a month to do a test to check the progress of the tumor, evaluate Symptoms of the tumor is small, it is worthy of our attention, it is worth our attention aspects.
Moderator: In our early preview of a problem that a lot of friends, eating Tarceva, pre-skin reaction, it does not reflect, but this is not from the resistance?
Dan Yuankai: should not be the case. rashes reflection occurs around a week after the general administration of the most obvious for some time, it is free to mitigation, not the symptoms reflected the effect of changes in the future. should not be interpreted this way.
Moderator: users will not worry about Tarceva resistant?
Dan Yuankai: any one drug, to a certain time, of resistance. This resistance is a time process. Some patients may eat a very long time, eat well, and some patients may eat very short time there will be the progress of the disease, and some patients had no effect resistance can also occur. resistance situation is different for each patient, can not be generalized, the analysis should be based on the specific situation.
expert users questions
Moderator: Professor Han of our users consult a problem. He was 79 years old, previously had lung cysts, and today found bloody sputum, and later discovered the cancer cells, but from both CT and chest X-ray can not see. Some doctors advise them to check the chest, but they are taking into account age too much, how can diagnosis?
Han Baohui: Because he did not provide details of the CT location, where, how, in what parts need to go to the hospital for further examination. He can be found in tumor cells is through sputum examination or through the organs examined. because the cancer may be associated with lymph node metastasis and other organs of the situation. If you want to design a treatment plan for him, we must first perform a comprehensive assessment of physical condition, it is necessary . I think he is qualified to go to a professional hospital, the first to be qualitative, is indeed cancer, lung cancer is indeed the second period to see where he belongs. Third, his overall assessment of health status and condition of . can be targeted to this patient to develop the most reasonable solution.
Moderator: There is a users in the use of Iressa, stand up and cough compared to the situation, and this is not the adverse drug reaction?
Han Baohui : did not know he was just starting to eat or eat due process, which judgment is quite different. because the nasal mucosa occurs, in the Iressa and other drugs can be met, he was such a situation, we also need to ask carefully. because of his data and information provided is not too full.
Moderator: cough side effects of targeted therapy is one of you?
Han Baohui: cough and not the relevance of targeted therapy because there are some very few patients have lung reflects the general examination of the patients will be provided through a special specific evidence. generally speaking cough and targeted therapy have not necessarily linked, it also requires a comprehensive consideration, because It's hard to simply say that there is no cough and targeted therapy relationship, but also the patient's chest condition, targeted therapy may be caused by a number of side effects, which is a process of identification.
how to treat patients with traditional Chinese medicine treatment of cancer?
Moderator: users are asking, is not in the process of targeted therapy will eat some of the overall rehabilitation of traditional Chinese medicine is better?
tension: It should be speaking, Chinese traditional medicine in our country, the efficacy of traditional medicine, there is no direct comparative study too. So, now we own point of view, assuming that no significant side effects, we have no objection to eat. Meanwhile, there are some combination of drugs will have some new material We do not advocate the use of patients when the drug, and then taking other drugs, so there will be a lot of other adverse reflection, we can not determine what drugs cause in the end. so under normal circumstances, we do not advocate, as are is an oral drug, we do not recommend mixing together. This situation will lead to adverse reactions, but also may affect the results. In this sense, we do not advocate the routine use of the drug combined with traditional Chinese medicine.
Dan Yuankai: Chinese categorized, there are a variety of mechanisms. There are some herbs on the human body has some side effects, some medicine to pass liver metabolism, it will produce some toxicity, does not mean that there is no toxicity of traditional Chinese medicine. If the two drugs together, may increase the number of side effects, the doctor determine the time necessary to increase the capacity of judge, may affect some of the truth, to bring the treatment to patients unnecessary trouble. If you do To select the medicine, then he should go to a regular hospital for Chinese medicine. please some well-known traditional Chinese medicine doctors give you medicine, so together the two drugs produce toxic side effects.

radiofrequency ablation treatment is the local host: Recently there are some on-line radiofrequency ablation to say, experts look to the resolution.
tension: the limitations of early lung cancer is a disease, we are the limitations of the principle limitations of the treatment of disease will. If it is late disease, with limited reach of treatment to achieve. for inoperable, but also an early lung cancer, radiofrequency ablation can be made by patients to be fully part of the radical, whether domestic or foreign has some relevant research . If it is advanced lung cancer patients, one lesion with a simple RF ablation, we believe that it does not affect the overall survival of patients. In this sense, we do not recommend for advanced lung cancer patients with this type of local treatment . If the tumor is large, affecting the patient's condition. through palliative radiofrequency ablation, to relieve symptoms temporarily. This situation is exceptional, in addition to the other, we do not advocate routine for RF ablation in patients with advanced methods. < br> After the failure of Iressa treatment, Castro opened the effectiveness?
Moderator: my father was 59 years old, in November 2007 found that the right pleural effusion, pleural microscope, many small nodules, and pleural biopsy obtained The pathology report is the large cell lung cancer, and then to the Beijing Union Medical College Hospital and your redo the pathological, the result, is undifferentiated, and sarcoma-like. obtained in your hospital plus cisplatin chemotherapy of non-selective, two a pleural effusion after treatment stopped, but the tumor grew, and later replaced with docetaxel plus cisplatin degree of grace, but invalid, then eat a month's Iressa, is also invalid, and one month before the start of hemoptysis, lung cancer is now growing rapidly, the patient physically weak, is now home cultivation, such as the physical condition has been restored you can continue to use the Te Luokai, such as Tarceva is invalid, what a good way, thank you, yearn for your reply .
ZHOU Cai-cun: the effect of the treatment the patient is not very good. second-line treatment has failed, and now third-line therapy has failed, in which case I can not say the concept of Tarceva did not work effectively. I can only tell the patient , Tarceva 150 mg when using the plasma concentration of 250 mg than 7 times higher in the case of no way, you can try a month, if that can control the tumor, even if effective, but other options are left not a lot. but there is no other program out of the case, you can try Tarceva. I can not tell him for sure is not effective or efficient.
tension: the users ask is, if you eat Iressa had no effect, there is no effect of Tarceva to eat how to do. to modern science, it is because the drug Iressa had a resistance gene, there are some drugs because of the amount of inhibitor drugs will be not enough happen. the patient for the treatment of drug, the concentration increased, the role of further control can be achieved. we can not judge the patient in the end because drug resistance genes produced dose or because not enough. I agree with Professor Zhou said, Tarceva can try, try this relatively low toxicity of the drug.
Moderator: experts, you are good! my husband in November 2007 found tracheal adenoid cystic carcinoma, tumor 1.5 * 1.3cm .12 circumcision surgery March 7, trachea 3.5cm. pathology report: the upper and lower cut-side are positive invasive adenoid cystic carcinoma. The doctor recommended radiotherapy .08 m3 on 7 January 3 January 34 to do radiation therapy (conformal , minor strength), physical examinations before radiotherapy were no other lesions, CT examination after radiotherapy compared with radiotherapy before: the rear tracheal lymph nodes was significantly reduced, doctors say radiation is better. But the end of radiotherapy 5 days a sudden hemoptysis (sputum more than blood for 20 days), send sputum cytology test 4 times, were found to have cancer. At present, some doctors recommend chemotherapy; but some doctors say chemotherapy for adenoid cystic carcinoma largely ineffective, but also serious side effects of physical injury Let us try to targeted therapy Tarceva. At present he does not know the true condition, good mental, physical recovery is also good, just a little cough, hemoptysis disappeared. please give some expert guidance: Next step how it treated? such as: the need to not chemotherapy, how much damage the body, can directly Tarceva, Tarceva tracheal adenoid cystic carcinoma of the invalid and so on. ask experts to the help.
Shiyuan Kai: He is 1.5t1.7 cm tumor of the tumor, although the location looks good, but the mass is so small, it should be said that the treatment effect is relatively good, the situation should be optional later find out the decision. If there is no recurrence of the tumor, I think patients do not need to rule out.
the direction of future development of targeted therapy
Moderator: Professor Han Baohui can look ahead at what the future development of targeted therapy?
Han Baohui: This topic is very large, targeted therapy ...